Advanced Filters
noise

Moscovskaya Oblast, Russian Federation Clinical Trials

A listing of Moscovskaya Oblast, Russian Federation clinical trials actively recruiting patients volunteers.

Found 148 clinical trials

Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

THE PURPOSE OF THE STUDY is to optimize the therapy of patients with primary B-cell precursor acute lymphoblastic leukemia (BCP-ALL) by including monoclonal bispecific antibodies in post-induction treatment with simultaneous reduction of chemotherapy. QUESTIONS AND OBJECTIVES OF THE STUDY: to determine the efficacy and feasibility of chemotherapy and immunotherapy combination …

1 - 18 years of age Both Phase N/A

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

It is an open-label dose-escalating study in sequential cohorts to assess safety and pharmacokinetics of GNR-084.

18 - 45 years of age Both Phase 1/2
O Oleg Savchuk, MD, PhD

Simultaneous Operations on the Thyroid Gland and Hyoid Suspension in Patients With Combined Thyroid Pathology and OSA

Simultaneous operations on the thyroid gland and hyoid suspension in patients with combined thyroid pathology and moderate to severe OSA.

30 - 60 years of age Male Phase N/A

An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis

Clinical study BCD-132-4/MIRANTIBUS is an international, multicenter, randomized, double-blind, double-masked study using an active reference drug (teriflunomide). The goal of the study is to evaluate the efficacy and safety of BCD-132 in the treatment of patients with relapsing multiple sclerosis.

18 - 60 years of age Both Phase 3
L Lena Smirnova

Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)

Juvenile nasopharyngeal angiofibroma (JNA) is a pathologically benign yet locally aggressive and destructive tumor that develops in the choana and nasopharynx. Historical treatment of JNA has included embolization, surgical resection, and radiation. mTOR signaling way demonstrated to be involved in regulation of growth and angiogenesis of JNA. Sirolimus, as mTOR …

7 - 18 years of age Male Phase 3
A Alina Aizenshtein

Oculomotor and Cognitive Rehabilitation Using Visual Feedback in Stroke Patients

Investigators will test the effectiveness of oculomotor cognitive training using eye tracker-based device during rehabilitation course in patients with a degree of disability no more than 3 points on a scale Rankin.

30 - 80 years of age Both Phase N/A
O Olga Dzhioeva

Auricular Vagus Stimulation in Obesity

Transcutaneous vagus nerve stimulation (TENS) involves stimulation of the left and/or right auricular branch of the vagus nerve with low-frequency electrical impulses. In recent years, the possibilities of using this technology in chronic conditions characterized by immune and metabolic dysregulation have been studied. The aim of this study is to …

18 - 75 years of age Both Phase N/A
A A SHCHENDRYGINA

Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Heart failure with preserved left ventricular ejection fraction (HFpEF) is a syndrome associated with high morbidity and mortality rates. Systemic low-grade inflammation is acknowledged to be a fundamental pathophysiological mechanism of HFpEF. Interventions targeting inflammatory pathway is understudied in HFpEF. Colchicine is a safe and well tolerated anti-inflammatory drug, which …

40 - 80 years of age Both Phase 1/2

Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis

The purpose of this study is to determine the effectiveness of minimally invasive decompression and fusion over the traditional open decompression and fusion in patients with single-level lumbar stenosis caused by degenerative spondylolisthesis. Postoperative follow-up will continue for 12 months. Сlinical, safety, radiological and cost-effectiveness endpoints will be evaluated.

40 - 75 years of age Both Phase N/A
M MAXIM BABAEV, D.Sc.(medical)

Efficacy and Safety of Hemoperfusion With Polymyxin B in Septic Shock Associated With Severe Endotoxemia in Cardiac Surgery Patients (РМХ vs SS)

Sepsis is a state of multiple organ dysfunction caused by a generalized immune-inflammatory response of the body to an infectious agent, with pronounced heterogeneity and interchangeability of clinical and laboratory manifestations. Violation of autoregulation and multiple organ dysfunctions in case of not timely started and / or ineffective therapy lead …

18 - 80 years of age Both Phase N/A

Rewrite in simple language using AI